(b) In GSD IV the breakdown of pathological glycogen is impaired, in turn requiring an increased baseline gluconeogenic flux to ensure normoglycemia, which is facilitated by increased expression of FBP1, PCK1, and PCK2, as shown in liver tissue of the GSD IV patient. Here, PCK2 is linked to glycogen storage disease due to glycogen branching enzyme deficiency.